Skip to main content
Home
NASTAD
  • About
  • Who We Are
  • What We Do
    • Teams
    • Initiatives
  • Issues
    • Anti-Racism
    • COVID-19
    • PrEP and PEP
    • Stigma
    • Testing
    • Housing
    • Undetectable = Untransmittable
    • Ending the HIV Epidemic
    • Ryan White Part B and ADAP
    • Gay Men's Health & Health Equity
    • Syringe Services Programs
    • Harm Reduction
    • Hepatitis Network for Education and Testing (HepNET)
  • Resources
  • Member Directory
Request TA
  • Newsroom
    • Blog
    • Press Releases
    • Newsletters
    • NASTAD in the News
  • Careers
  • Events
  • Donations & Payments
Search the site
Newsroom

In the News

What is xylazine, and how is it contributing to overdose deaths?

Mar 28, 2023
Read more

An Evaluation of the Successes of the NASTAD Minority Leadership Program and Its Implications for Leadership in State Health Departments

Mar 24, 2023
Read more

All News

340B Informed: 340B Is Key in the Fight to End Viral Hepatitis

Jun 7, 2022

Public Health Review Morning Edition: All-Star TechXpo Lineup Revealed

May 6, 2022

Slate: Send Every American a Free Home HIV Test

Mar 16, 2022

Physician's Weekly: Communicating During an HIV Outbreak Among People Who Inject Drugs-West Virginia 2019

Jan 18, 2022

Avalere Health Essential Voice: HIV/AIDS Prevention and Treatment, Part II

Dec 9, 2021

NBC News: 'This will shut us down': HIV prevention clinics brace for Gilead reimbursement cuts

Jul 14, 2021

Poz: Generic PrEP Highlights How Even Low-Cost HIV Care Relies on High Drug Prices

May 7, 2021

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Next ›
  • Last »

Stay Up to Date

HIV/AIDS and hepatitis news delivered straight to your inbox.
Sign up
  • Who We Are
    • About NASTAD
    • Our Team
    • Contact Us
    • Careers
  • Newsroom
    • Blog
    • Press Releases
    • Newsletters
    • In the News
  • Membership
    • Training & Technical Assistance
    • Member Directory
    • Donations & Payments
  • Connect With Us
    • Facebook
    • Instagram
    • Twitter
    • LinkedIn
    • YouTube

NASTAD is a CDC-funded Capacity Building Assistance (CBA) Provider

©2023 NASTAD | Privacy Policy | 202.434.8090